Treatment of Recurrent Oral Candidiasis (Thrush)
For recurrent oral candidiasis, fluconazole 100 mg three times weekly is strongly recommended as chronic suppressive therapy when required for patients with frequent recurrences. 1
Initial Treatment Based on Disease Severity
Mild Disease
First-line options:
Alternative options for mild disease:
Moderate to Severe Disease
Management of Fluconazole-Refractory Disease
If initial treatment with fluconazole fails:
First alternatives:
Second alternatives:
For severe refractory disease:
Management of Recurrent Oral Candidiasis
For patients with recurrent infections requiring chronic suppressive therapy:
- Fluconazole: 100 mg three times weekly 1, 2
- This regimen has been shown to effectively prevent recurrences with minimal side effects 5
Special Considerations
HIV-Infected Patients
- Antiretroviral therapy is strongly recommended to reduce the incidence of recurrent infections 1, 2
- Recurrent thrush in HIV patients may indicate immune dysfunction, particularly with CD4 counts <200 cells/μL 1
Denture-Related Candidiasis
- Disinfection of the denture in addition to antifungal therapy is essential 1, 2
- Recommendations for denture care:
- Remove dentures at night
- Clean thoroughly with appropriate denture cleaners
- Consider denture replacement if ill-fitting 2
Common Pitfalls and Caveats
Failure to identify and address underlying risk factors:
- Immunosuppression
- Diabetes mellitus
- Broad-spectrum antibiotic use
- Corticosteroid use (including inhaled steroids)
- Poor oral hygiene
Inadequate treatment duration:
- Premature discontinuation of therapy before complete resolution can lead to recurrence
Failure to recognize fluconazole resistance:
Neglecting denture hygiene:
Ignoring the possibility of progression to systemic infection:
- In severely immunocompromised patients, oral thrush can potentially lead to candidemia, especially with resistant strains 7
Remember that single-dose fluconazole (150 mg), while effective for vaginal candidiasis 8, is not the recommended regimen for oral thrush, though it has shown efficacy in some palliative care settings 9.